CoChat

Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder

Open access
Grubman, Alexandra, Lidgerwood, Grace E, Duncan, Clare, Bica, Laura, Tan, Jiang-Li, Parker, Sarah J, Caragounis, Aphrodite, Meyerowitz, Jodi, Volitakis, Irene, Moujalled, Diane, Liddell, Jeffrey R, Hickey, James L, Horne, Malcolm, Longmuir, Shoshanah, Koistinaho, Jari, Donnelly, Paul S, Crouch, Peter J, Tammen, Imke, White, Anthony R, Kanninen, Katja M · 2014 · Acta Neuropathologica Communications
Cited by 40

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Aberrant biometal metabolism is a key feature of neurodegenerative disorders including Alzheimer's and Parkinson's diseases. Metal modulating compounds are promising therapeutics for neurodegeneration, but their mechanism of action remains poorly understood. Neuronal ceroid lipofuscinoses (NCLs), caused by mutations in CLN genes, are fatal childhood neurodegenerative lysosomal storage diseases without a cure. We previously showed biometal accumulation in ovine and murine models of the CLN6 variant NCL, but the mechanism is unknown. This study extended the concept that alteration of biometal functions is involved in pathology in these disorders, and investigated molecular mechanisms underlying impaired biometal trafficking in CLN6 disease. RESULTS: We observed significant region-specific biometal accumulation and deregulation of metal trafficking pathways prior to disease onset in CLN6 affected sheep. Substantial progressive loss of the ER/Golgi-resident Zn transporter, Zip7, which colocalized with the disease-associated protein, CLN6, may contribute to the subcellular deregulation of biometal homeostasis in NCLs. Importantly, the metal-complex, ZnII(atsm), induced Zip7 upregulation, promoted Zn redistribution and restored Zn-dependent functions in primary mouse Cln6 deficient neurons and astrocytes. CONCLUSIONS: This study demonstrates the central role of the metal transporter, Zip7, in the aberrant biometal metabolism of CLN6 variants of NCL and further highlights the key contribution of deregulated biometal trafficking to the pathology of neurodegenerative diseases. Importantly, our results suggest that ZnII(atsm) may be a candidate for therapeutic trials for NCLs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2051-5960-2-25

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 40

Metadata

Authors
Grubman, A., Lidgerwood, G. E., Duncan, C., Bica, L., Tan, J.-L., Parker, S. J., Caragounis, A., Meyerowitz, J., Volitakis, I., Moujalled, D., Liddell, J. R., Hickey, J. L., Horne, M., Longmuir, S., Koistinaho, J., Donnelly, P. S., Crouch, P. J., Tammen, I., White, A. R., & Kanninen, K. M.
Venue
Acta Neuropathologica Communications
Published
2014-02-28
Volume
2
Issue
1
Pages
25-25
ISSN
2051-5960 (ISSN-L)
OpenAlex
W2103270725
Cited by
40
References
4
FWCI
4.28
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder. https://app.cochat.ai/papers/10.1186/2051-5960-2-25
The paper
Grubman, A., Lidgerwood, G. E., Duncan, C., Bica, L., Tan, J.-L., Parker, S. J., Caragounis, A., Meyerowitz, J., Volitakis, I., Moujalled, D., Liddell, J. R., Hickey, J. L., Horne, M., Longmuir, S., Koistinaho, J., Donnelly, P. S., Crouch, P. J., Tammen, I., White, A. R., & Kanninen, K. M. (2014). Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder. Acta Neuropathologica Communications. https://doi.org/10.1186/2051-5960-2-25

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.